{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

A survey to assess the usage pattern of amisulpride in the management of schizophrenia in India

Survey Questionnaire Form
Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. How many patients of schizophrenia do you see in a month? *

  2. In your clinical practice, what percentage of your total patient population are diagnosed with schizophrenia? *

  3. In your clinical practice, schizophrenia is observed more in_____ *

  4. In your clinical experience, schizophrenia is more commonly diagnosed in which age group of patients? *

  5. How often do you encounter first-episode schizophrenia in your practice? *

  6. What are the most common positive symptoms observed in your patients with schizophrenia? *

  7. What are the most common negative symptoms observed in your patients with schizophrenia? *

  8. As per your clinical experience, which factors are critical for choosing first-line treatment option in the management of schizophrenia? *
  9. How frequently do you prescribe Amisulpride for schizophrenia patients in your clinical practice? *

  10. What is the usual starting dose of amisulpride in your practice for treatment of positive symptoms in schizophrenia? *

  11. What is the usual starting dose of amisulpride in your practice for treatment of negative symptoms in schizophrenia? *

  12. What factors influence your decision to prescribe Amisulpride over other antipsychotics for schizophrenia? *
  13. How effective is Amisulpride in managing positive symptoms of schizophrenia according to your experience? *

  14. How effective is Amisulpride in managing negative symptoms of schizophrenia according to your practice? *

  15. What is the typical duration of Amisulpride treatment for acute schizophrenia episodes in your patients? *

  16. Do you use Amisulpride as monotherapy or in combination with other medications for schizophrenia management? *

  17. What percentage of your schizophrenia patients currently take Amisulpride? *

  18. Based on your clinical practice, does amisulpride has lesser risk of weight gain, glucose tolerance compared to other antipsychotics? *

  19. What is your approach for managing metabolic side effects associated with Antipsychotics? *
  20. Do you prefer Amisulpride in specific subtypes of schizophrenia (e.g., treatment-resistant, first episode)? *

  21. How often do you switch patients from other antipsychotics to Amisulpride due to inadequate response or intolerable side effects? *

  22. What is your preferred augmentation strategy if Amisulpride monotherapy is insufficient for symptom control? *
  23. How often do you conduct follow-up visit for patients on Amisulpride for schizophrenia? *

  24. How frequently do you combine psychotherapy with Amisulpride treatment in schizophrenia patients? *

  25. What is your preferred method for assessing treatment response to Amisulpride in schizophrenia? *
  26. What are your thoughts on the overall tolerability and efficacy of Amisulpride compared to other antipsychotics in the management of schizophrenia? *

  27. How do you educate patients about Schizophrenia? *

  28. Mention some initial instructions/advice you give to your patients before initiating the Amisulpride for the treatment of schizophrenia *
  29. How often do you encounter medication non-adherence among your patients with schizophrenia? *

  30. What is your preferred approach to addressing medication non-adherence in schizophrenia patients? *